A unique folate hydrolase, prostate-specific membrane antigen (PSMA): a target for immunotherapy?

Tasch, J; Gong, M; Sadelain, M; Heston, W D

Tasch, J; Gong, M; Sadelain, M; Heston, W D.

Affiliation

Tasch J; Department of Urology, Memorial Hospital, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Crit Rev Immunol ; 21(1-3): 249-61, 2001.

Article in En | MEDLINE | ID: mdl-11642607

Subject(s)

Antigens, Surface; Carboxypeptidases/analysis; Prostatic Neoplasms/therapy; Alternative Splicing; Animals; Antibodies, Monoclonal; Binding Sites; Cancer Vaccines/immunology; Carboxypeptidases/genetics; Cloning, Molecular; Genetic Therapy; Glutamate Carboxypeptidase II; Humans; Male; Mice; Prostate/diagnostic imaging; Prostatic Neoplasms/immunology; Radionuclide Imaging

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Carboxypeptidases / Antigens, Surface Limits: Animals / Humans / Male Language: En Journal: Crit Rev Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2001 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links